Evidence map›Paper›PMID 26082613›Full record

ReviewDrug design, development and therapy2015

Applications of calixarenes in cancer chemotherapy: facts and perspectives.

Ali Yousaf, Shafida Abd Hamid, Noraslinda M Bunnori, A A Ishola

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Nanoarchitectonics and Simulation on the Molecular-Level Interactions betweenLangmuir : the ACS journal of surfaces and colloids · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Pillar[RSC advances · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Role of Calixarene in Chemotherapy Delivery Strategies.Molecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ali YousafKulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, Malaysia.
Shafida Abd HamidKulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, Malaysia.
Noraslinda M BunnoriKulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, Malaysia.
A A IsholaKulliyyah of Medicine, International Islamic University Malaysia, Bandar Indera Mahkota, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research on the therapeutic applications of calixarene derivatives is an emerging area of interest. The anticancer activity of various functionalized calixarenes has been reported by several research groups. Due to their superior geometric shape, calixarenes can accommodate drug molecules by forming inclusion complexes. Controlled release of anticancer drugs by calixarenes might help in targeted chemotherapy. This review summarizes the anticancer potential of the calixarenes and their drug loading properties. The potential use of calixarenes in chemoradiotherapy is also highlighted in brief.

Indexed as

AnimalsAntineoplastic AgentsCalixarenesChemoradiotherapyDelayed-Action PreparationsHumansNeoplasmsAntineoplastic AgentsCalixarenesDelayed-Action Preparationscalixarenescancerchemotherapy

Identifiers

PMID26082613
PMCPMC4459628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.